News

The termination of one of three Phase 3 rheumatoid arthritis registration studies of the anti-BAFF monoclonal antibody is not due to safety concerns and patients presently enrolled in

The solution also allows the research files to be automatically uploaded into the correct file, without human intervention. I-Batch eliminates the manual document sorting and uploading process by

The trial was designed to evaluate safety and also to provide proof-of-concept for the ability of the compound to inhibit excessive uterine contractility. During the study the healthy

The BZA/CE is an investigational therapy developed by Wyeth Pharmaceuticals to tackle symptoms such as vasomotor symptoms and vulvar and vaginal atrophy associated with menopause and for prevention

MM-141, the company’s sixth oncology candidate that advanced into clinical development, is developed to target P13K/AKT/mTOR pathway that is believed to play a vital role in tumor cell

Patients enrolled in open label multicenter study established constant improvement in lesions throughout the study and demonstrated 42% reduction in eight weeks. XBiotech president and CEO John Simard

The deal allows Genmab, which received €7.5m upfront payment previously, to develop human antibodies against three central nervous system targets identified by Lundbeck. Lundbeck, which will entirely fund

The CardioSCORE test is a patented diagnostic blood test designed to improve risk prediction of major cardiovascular events beyond traditional risk factor assessments, such as the Framingham Risk

The data has also reported positive clinical response activity in classical Hodgkin Lymphoma (HL) patients, who could be the target population for future studies. Sponsored by the Fondazione